MedTrace Logo

Comparison of the Efficacy and Safety of NALDEBAIN With Conventional Treatment After Laparoscopic Cholecystectomy

NCT03713216 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-07-16

No results posted yet for this study

Summary

To determine the effect and safety of NALDEBAIN versus Morphine as needed in patients after laparoscopic cholecystectomy.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Naldebain

150 mg Nalbuphine sebacate

DRUG

Morphine

Morphine

Sponsors & Collaborators

  • Cathay General Hospital

    lead OTHER

Principal Investigators

  • Sing-Ong Lee, MD · Cathay General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2019-10-01
Completion
2020-01-01

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03713216 on ClinicalTrials.gov